Le Lézard
Classified in: Health
Subjects: NPT, CHI, NTA, DEI

Partnership With Native Americans Teams With Operation Warm and Molina Complete Care of Arizona to Deliver Free Coats to Kids


PHOENIX and SAN CARLOS, Ariz., Oct. 25, 2022 /PRNewswire/ -- Partnership With Native Americans (PWNA), a Native-led nonprofit serving remote reservations in the southwest and northern plains regions of the U.S., teamed up with Operation Warm and Molina Complete Care of Arizona ("Molina") to provide the gift of new coats to elementary students in Arizona.

New coats were provided to every child at two K-6 schools on the San Carlos Reservation in San Carlos, which has a poverty rate of approximately 54%. The distributions took place at St. Charles Apache Mission School with 121 students and Rice Elementary with 727 students, both longtime partner schools of PWNA.

"Less than 1% of all charitable giving supports Native American causes, yet 61% of Native children live in poverty or low-income households," said Joshua Arce, president and CEO of PWNA. A lack of retail stores and jobs on reservations make it difficult for families to secure coats and other seasonal apparel for their children, amid temperatures that dip below freezing. "This partnership is a good example of how organizations can effectively team up to make a difference for one of the most vulnerable populations in our country. We thank Operation Warm and Molina for supporting this important initiative as we approach winter."

"Molina's mission is to improve the health and lives of our members and communities by delivering high-quality health care and support resources," said Minnie Andrade, plan president of Molina Complete Care of Arizona. "We are grateful for the opportunity to partner with PWNA and Operation Warm to help children stay warm and comfortable during the winter months."

"We are grateful to be a part of this wonderful initiative alongside PWNA and Molina," says Grace Sica, executive director of Operation Warm. "Something as simple as a warm winter coat can make a big difference in a child's life."

ABOUT PWNA

PWNA is a Native-led nonprofit committed to championing hope for a brighter future for Native Americans living on remote, geographically isolated and under-resourced reservations. Established in 1990, PWNA collaborates with reservation programs to serve immediate needs and support long-term solutions for strong, self-sufficient Tribal communities, improving life for 250,000 Native Americans annually. For more about PWNA, visit NativePartnership.org.

ABOUT MOLINA HEALTHCARE

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Molina Healthcare served approximately 5.1 million members as of June 30, 2022, located across 19 states. For more information about Molina Healthcare, please visit molinahealthcare.com.

ABOUT OPERATION WARM

Operation Warm is a national nonprofit that manufactures brand-new, high-quality coats and shoes for children in need. We partner with compassionate individuals, community organizations, and corporations across North America to connect underserved?children?to?the community resources?they need to thrive.?Over the last 23 years, Operation Warm and our partners have offered the gifts of brand-new coats and shoes as a bridge for families in need to access everything from flu shots to new books.?To make a lasting impact on the lives of children, visit operationwarm.org.? 

Media Contact: 
Helen Oliff 
(540) 825-5950 x205 
[email protected]

SOURCE Partnership With Native Americans


These press releases may also interest you

at 06:00
BioInvent International (STO:BINV)Preliminary data presented at ESMO 2024 demonstrate BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatmentIn a patient with a heavily pretreated leiomyosarcoma, BT-001 was able to...

at 05:00
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials;...

at 04:20
Pfizer Inc. today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for patients with BRAF V600E-mutant...

at 04:06
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced the latest clinical data on...

at 03:20
Merck , known as MSD outside of the United States and Canada, today announced overall survival (OS) results from the final analysis of the Phase 3 KEYNOTE-811 trial evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with...

at 03:10
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced positive pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies evaluating taletrectinib, an...



News published on and distributed by: